Tri-iodothyronine supplement protects gut barrier in septic rats

World Journal of Gastroenterology

Volumn 9, Issue 2, 2003, Pages 347-350

  Yang, Zhi Li ^a   Yang, Lian Yue ^a   Huang, Geng Wen ^a   Liu, He Li ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LIOTHYRONINE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FLUORESCENCE SPECTROSCOPY; FREE THYROXINE INDEX; HISTOLOGY; INTESTINE; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; LIGATION; LIOTHYRONINE BLOOD LEVEL; MALE; MICROSCOPY; MORPHOLOGY; NONHUMAN; PERMEABILITY BARRIER; PUNCTURE; RADIOIMMUNOASSAY; RAT; SEPSIS; STATISTICAL ANALYSIS; STOMACH PROTECTION; SUPPLEMENTATION; SYMPTOM; THYROXINE BLOOD LEVEL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0037442043     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i2.347     Document Type: Article

References (40)

1. Moore FA. Role of gastrointestinal tract in the postinjury multiple organ failure. Am J Surg 1999; 178: 449-453
2. Deitch EA. Multiple organ failure: Pathophysiology and potential future therapy. Ann Surg 1992; 216: 117-134
3. Wu CT, Li ZL, Xiong DX. Relationship between enteric microecologic dysbiosis and bacterial translocation in acute necrotizing pancreatitis. World J Gastroenterol 1998; 4: 242-245
4. Yu JH, Ni RY, Luo DO, Li SL. Intestinal flora translocation and overgrowth in upper gastrointestinal tract induced by hepatic failure. World J Gastroenterol 1999; 5: 327-329
5. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut 1999; 44: 890-895
6. Kouris GJ, Liu Q, Rossi H, Djuricin G, Gattuso P, Nathan C, Weinstein RA, Prinz RA. The effect of glucagons-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis. Am J Surg 2001; 181: 571-575
7. Wang FJ, Zhao Y, Wang P, Wang SL, Liu J, Zhou X. Effects of glucagons-like peptide-2 on intestinal barrier function in severely burned rats. Shijie Huaren Xiaohua Zazhi 2002; 10: 796-799
8. Benjamin MA, McKay DM, Yang PC, Cameron H, Perdue MH. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 2000; 47: 112-119
9. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Mush MM, Chang EB. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001; 16: 398-402
10. Zhou X, Li YX, Li N, Li JS. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: Animal experiment. World J Gastroenterol 2001; 7: 66-73
11. Utiger RD. Altered thyroid function in nonthyroidal illness and surgery: To treat or not to treat? N Engl J Med 1995; 333: 1562-1563
12. Yang LY, Huang GW. Advance and development of sick syndrome of normal thyroid in surgical sever patients. Zhongguo Shiyong Waike Zazhi 2000; 20: 114-115
13. Liu JH, Yang LY. Advance and development of research of protective mechanism of organ function by thyroxine. Zhongguo Shiyong Waike Zazhi 2001; 21: 372-374
14. Dulchavsky SA, Bailey J. Triiodothyronine treatment maintains surfactant synthesis during sepsis. Surgery 1992; 112: 475-479
15. Jeevanandam V, Todd B, Regillo T, Hellman S, Eldridge C, Mcclurken J. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994; 13: 681-687
16. Chapital AD, Hendrick SR, Lloyd L, Pieper D. The effects of triiodothyronine augmentation on antithrombin III levels in sepsis. Am Surg 2001; 67: 253-255
17. Ardawi MSM, Jalalah SM. Effects of hypothyroidism on glucose and glutamine metabolism by the gut of the rat. Clin Science 1991; 81: 347-355
18. Wichterman KA, Chaudry IH, Baue AE. Studies of peripheral glucose uptake during sepsis. Arch Surg 1979; 114: 740-743
19. Chen LW, Hsu CM, Cha MC, Che JS, Chen SC. Changes in gut mucosal nitric oxide synthase(NOS) activity after thermal injury and its relation with barrier failure. Shock 1999; 11: 104-110
20. 3 syndrome during caloric deprivation and non-thyroidal illness: An overview. Acta Med Kaust 1988; 15: 42-45
21. Chow CC, Mak TW, Chan CH, Cockram CS. Euthyroid sick syndrome in pulmonary tuberculosis before and after treatment. Ann Clin Biochem 1995; 32: 385-391
22. Phillips RH, Valente WA, Caplan ES, Connor TB, Wiswell JG. Circulating thyroid hormone changes in acute trauma: Prognostic implications for clinical outcome. J Trauma 1984; 24: 116-119
23. Huang GW, Yang LY, Yang JQ. Role of thyroid hormone in the protection of intestinal mucosal barrier of septic rats. Zhonghua Shiyan Waike Zazhi 2000; 17: 531-532
24. Cheren HJ, Nellen HH, Barabejski FG, Chong MBA, Lifshitz GA. Thyroid function and abdorminal surgery. A longitudinal study. Arch Med Res 1992; 23: 143-147
25. Yang LY, Liu HL. Application of thyroxine in surgery. Zhongguo Shiyong Waike Zazhi 2001; 21: 328-329
26. 3 syndrome following acute myocardial infarct. Klin Wochenschrift 1987; 65: 129-133
27. Eber B, Schumacher M, Langsteger W, Zweiker R, Fruhwald FM, Pokan R, Gasser R, Eber O, Klein W. Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology 1995; 86: 152-156
28. Holland FW, Brown PS, Weintraub BD, Clark RE. Cardiopulmonary by pass and thyroid function: A "euthyroid sick syndrome". Ann Thorac Surg 1991; 52: 46-50
29. Vexiau P, Perez-Castiglioni P, Socie G, Devergie A, Toubert ME, Aracting S, Gluckman E. The "euthyroid sick syndrome": Incidence, risk factors and prognostic value soon after allogeneic bone marrow transplantation. Br J Hematol 1993; 85: 778-782
30. De Groot LJ. Dangerous dogmas in medicine: The nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999; 84: 151-164
31. Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T Seo H. A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome. J Clin Invest 2000; 106: 393-402
32. Yang LY, Hu M, Huang YS. The relation of critic septic shock and peripheric metabolism malfunction of thyroxine. Zhonghua Shiyan Waike Zazhi 1990; 7: 134-135
33. Shieh P, Zhou M, Ornan DA, Chaudry IH, Wang P. Upregulation of inducible nitric oxide synthase and nitric oxide occurs later than the onset of the hyperdynamic response during sepsis. Shock 2000; 13: 325-329
34. Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996; 270: R927-938
35. Moley JF, Ohkawa M, Chaudry IH, Clemens MG, Baue AE. Hypothyroidism abolishes the hyperdynamic phase and increases susceptibility to sepsis. J Surg Res 1984; 36: 265-273
36. Tabrizi AR, Zehnbauer BA, Freeman BD, Buchman TG. Genetic markers in sepsis. J Am Coll Surg 2001; 192: 106-117
37. Antonsson JB, Fiddian-Green RG. The role of the gut in shock and multiple system organ failure. Eur J Surg 1991; 157: 3-12
38. Travis S, Menzies I. Intestinal permeability: Functional assessment and significance. Clin Sci 1992; 82: 471-488
39. Smith TJ, Drummand GS, Kourides IA, Kappas A. Thyroid horomone regulation of heme oxidation in the liver. Proc Natl Acad Sci USA 1982; 79: 7537-7541
40. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AMK. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Bio Chem 1997; 272: 5375-5381